- Home
- CTMX vs VLGEA Comparison
CTMX vs VLGEA Comparison
Compare CTMX & VLGEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- VLGEA
- Stock Information
- Founded
- CTMX 2008
- VLGEA 1937
- Country
- CTMX United States
- VLGEA United States
- Employees
- CTMX N/A
- VLGEA N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- VLGEA Food Chains
- Sector
- CTMX Health Care
- VLGEA Consumer Staples
- Exchange
- CTMX Nasdaq
- VLGEA Nasdaq
- Market Cap
- CTMX 596.2M
- VLGEA 480.8M
- IPO Year
- CTMX 2015
- VLGEA N/A
- Fundamental
- Price
- CTMX $3.39
- VLGEA $32.09
- Analyst Decision
- CTMX Strong Buy
- VLGEA
- Analyst Count
- CTMX 5
- VLGEA 0
- Target Price
- CTMX $5.80
- VLGEA N/A
- AVG Volume (30 Days)
- CTMX 3.0M
- VLGEA 64.0K
- Earning Date
- CTMX 11-07-2025
- VLGEA 12-02-2025
- Dividend Yield
- CTMX N/A
- VLGEA 3.12%
- EPS Growth
- CTMX 263.20
- VLGEA 12.16
- EPS
- CTMX 0.49
- VLGEA 3.81
- Revenue
- CTMX $141,100,000.00
- VLGEA $2,320,690,000.00
- Revenue This Year
- CTMX N/A
- VLGEA N/A
- Revenue Next Year
- CTMX N/A
- VLGEA N/A
- P/E Ratio
- CTMX $6.79
- VLGEA $8.43
- Revenue Growth
- CTMX 18.01
- VLGEA 3.76
- 52 Week Low
- CTMX $0.40
- VLGEA $28.33
- 52 Week High
- CTMX $3.91
- VLGEA $40.15
- Technical
- Relative Strength Index (RSI)
- CTMX 57.06
- VLGEA 38.26
- Support Level
- CTMX $3.21
- VLGEA $31.61
- Resistance Level
- CTMX $3.50
- VLGEA $33.43
- Average True Range (ATR)
- CTMX 0.25
- VLGEA 0.79
- MACD
- CTMX -0.06
- VLGEA 0.06
- Stochastic Oscillator
- CTMX 35.42
- VLGEA 43.79
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About VLGEA Village Super Market Inc.
Village Super Market Inc operates a chain of ShopRite supermarkets, a few of which are in northern New Jersey, southern New Jersey, Maryland, and in northeastern Pennsylvania. The company is a member of Wakefern Food Corporation (Wakefern), a retailer-owned food cooperative and owner of the ShopRite name. It consists of one operating segment, the retail sale of food and nonfood products.